Banks Benefit From ...
Technology: Electronics
IRIS International Inc. (IRIS: NASDAQ)
$10.50 -0.09 | -0.85%
02/09/12 - 04:00 PM ET
43.83K / 62.80K
Vol / Avg. Vol:10.60 / 10.59
Open / Prev. Close:10.42 - 10.65
Today's Range:7.73 - 10.69
52 Wk Range:13.26%
Performance YTD:TheStreet Rating:
Portfolios with IRIS
- Portfolio NameUser Type
- UserLarry Tech Portfolio 1
- UserGet Rich Quick
- UserRimney's 4 Chaos
- UserRoar
- Usergood-buddy Portfolio 1
- UserBUY LIST HIGHLIGHTS - 11-27-07
- Userjojos Portfolio 1
- Userfoobar123
- UserRedhorse Portfolio 1
- UserPT
Latest IRIS Headlines from TheStreet
- IRIS International Receives FDA 510(k) Clearance For Its IChem(R)VELOCITY(TM) Automated Urine Chemistry Analyzer And IRICELL(R) Urinalysis Workstation 03.24.11 | 02:03 pm
- IRIS International Awarded Extension Of Federal Supply Schedule By U.S. Department Of Veteran Affairs 03.03.11 | 07:03 am
- IRIS International Reports Record Revenue For 2010 Fourth Quarter And Full Year 02.28.11 | 04:02 pm
- IRIS International's Sample Processing Division Extends Exclusive Supply Agreement With IDEXX Laboratories For An Additional Five Years 02.24.11 | 02:02 pm
- IRIS International's NADiA(R)ProsVue(TM) Prognostic Prostate Cancer Test Data From Multi-Center Clinical Study Presented At ASCO 2011 Genitourinary Cancers Symposium 02.17.11 | 03:02 pm
- IRIS International Appoints Dr. Richard A. O'Leary As Corporate Vice President, Human Resources And Administration 02.15.11 | 07:02 am
- IRIS To Release Fourth Quarter Financial Results And Host Conference Call And Webcast On Monday, February 28, 2011 02.15.11 | 07:02 am
- IRIS International To Present At Citi 2011 Global Healthcare Conference On March 2, 2011 02.01.11 | 07:02 am
- IRIS International Achieves Significant Inroads In Mexican Market With Placement Of 40 IQ(R)200 Automated Urine Microscopy Analyzers In 2010 01.25.11 | 07:01 am
- IRIS International Ships 3,000th IQ(R)200 Automated Urine Microscopy Analyzer 01.05.11 | 07:01 am
Press Releases for IRIS
Partner Headlines for IRIS
- UPDATE: The Benchmark Company Upgrades Rating to Hold and Raises PT to $8.50 on IRIS International - Benzinga 11.04.11 | 09:11 am
- IRIS International Receives FDA 510(k) Clearance for Its NADiA ProsVue Prognostic Cancer Test - Benzinga 09.22.11 | 01:09 pm
